Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. AMD
4. INFY
5. RNG
6. UNP
7. DGX
8. ACI
9. URI
10. ARGX

Go back to Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors
(NASDAQ: PVLA) Delayed: 143.21 --0 (-0%)
Previous Close $143.21    52 Week High $ 
Open $143.21    52 Week Low $ 
Day High $143.21    P/E N/A 
Day Low $143.21    EPS $ 
Volume 16